Fideuram Intesa Sanpaolo Private Banking S.P.A. Reduces Position in Colgate-Palmolive Company $CL

Fideuram Intesa Sanpaolo Private Banking S.P.A. trimmed its position in shares of Colgate-Palmolive Company (NYSE:CL) by 13.4% during the 1st quarter, HoldingsChannel.com reports. The firm owned 159,969 shares of the company’s stock after selling 24,800 shares during the quarter. Fideuram Intesa Sanpaolo Private Banking S.P.A.’s holdings in Colgate-Palmolive were worth $13,634,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in Colgate-Palmolive by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 83,947,987 shares of the company’s stock valued at $6,633,570,000 after acquiring an additional 1,026,985 shares during the period. Geode Capital Management LLC grew its position in Colgate-Palmolive by 1.4% in the 4th quarter. Geode Capital Management LLC now owns 22,103,901 shares of the company’s stock valued at $1,754,657,000 after acquiring an additional 304,426 shares during the last quarter. Morgan Stanley increased its stake in Colgate-Palmolive by 1.7% in the fourth quarter. Morgan Stanley now owns 19,246,217 shares of the company’s stock worth $1,520,836,000 after purchasing an additional 323,367 shares during the period. Norges Bank bought a new stake in shares of Colgate-Palmolive during the fourth quarter worth $861,670,000. Finally, Deutsche Bank AG lifted its position in shares of Colgate-Palmolive by 33.9% during the fourth quarter. Deutsche Bank AG now owns 10,845,857 shares of the company’s stock worth $857,040,000 after purchasing an additional 2,746,920 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

CL opened at $95.17 on Friday. The company has a market capitalization of $76.15 billion, a price-to-earnings ratio of 37.03, a PEG ratio of 4.89 and a beta of 0.33. The company has a current ratio of 1.02, a quick ratio of 0.67 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a 12-month low of $74.54 and a 12-month high of $99.33. The business’s fifty day simple moving average is $88.81 and its 200-day simple moving average is $87.56.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a return on equity of 386.76% and a net margin of 10.04%.The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. During the same period in the previous year, the company posted $0.91 earnings per share. The firm’s quarterly revenue was up 8.4% on a year-over-year basis. On average, equities research analysts anticipate that Colgate-Palmolive Company will post 3.81 earnings per share for the current fiscal year.

Colgate-Palmolive Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Monday, July 20th will be issued a $0.53 dividend. The ex-dividend date is Monday, July 20th. This represents a $2.12 annualized dividend and a dividend yield of 2.2%. Colgate-Palmolive’s payout ratio is currently 82.49%.

Analysts Set New Price Targets

CL has been the topic of a number of research analyst reports. The Goldman Sachs Group restated a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. Royal Bank Of Canada reissued an “outperform” rating and issued a $102.00 price objective on shares of Colgate-Palmolive in a research report on Monday, May 4th. JPMorgan Chase & Co. upped their target price on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, May 4th. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $100.00 to $92.00 and set an “equal weight” rating on the stock in a research report on Wednesday, April 8th. Finally, Wall Street Zen downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Sunday, March 29th. Twelve investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $95.88.

Colgate-Palmolive Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.